Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs

A retrospective case-control study was conducted at Modena University Hospital from December 2017 to January 2019 to identify risk factors and predictors of MDR/XDR Pseudomonas aeruginosa (PA) isolation with resistance to ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T), and of mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Meschiari, Marianna, Orlando, Gabriella, Kaleci, Shaniko, Bianco, Vincenzo, Sarti, Mario, Venturelli, Claudia, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532599/
https://www.ncbi.nlm.nih.gov/pubmed/34680805
http://dx.doi.org/10.3390/antibiotics10101224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532599/
https://www.ncbi.nlm.nih.gov/pubmed/34680805
http://dx.doi.org/10.3390/antibiotics10101224

Ejemplares similares